trending Market Intelligence /marketintelligence/en/news-insights/trending/k39v-ivyop0_z0bwtdryjw2 content esgSubNav
In This List

Maricann completes acquisition of Swiss marijuana producer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Maricann completes acquisition of Swiss marijuana producer

Maricann Group Inc. completed the acquisition of all outstanding shares of Haxxon AG, a Switzerland-based marijuana producer.

Langton, Ontario-based medical cannabis producer said the acquisition "forms a critical element" of its European expansion strategy and will help it to enter the Swiss market through Haxxon's production of feminized high cannabidiol cannabis plants.

Maricann paid CHF 2 million cash and will issue 3,848,505 common shares to Haxxon within 10 days of closing.

The company will issue up to an additional 132,707 common shares two years after closing of the transaction, provided certain representations and warranties of the seller remain in good standing.